What is the end year of AbbVie’s patent for Teflaro?
I don’t have enough information from the provided material to determine the end (expiration) year of AbbVie’s patent covering Teflaro.
To answer accurately, I would need at least one of the following details:
- the patent number or application number, or
- the country/region (US, EU, UK, etc.), or
- a link/screenshot to the patent listing you’re referring to, or
- whether you mean the active patent term date or the full exclusivity end date (which can include extensions).
Which country’s patent date matters?
Patent expiration can differ by jurisdiction because term calculations, extensions, and exclusivity rules vary by country. If you tell me the jurisdiction (for example, “US Orange Book” vs “EU SPC”), I can give the correct end year for that specific filing.
Is this about patent term or exclusivity (SPC/paediatric/other extensions)?
Sometimes “end year” is used interchangeably for:
- the end of the patent term itself, or
- the end of market exclusivity driven by regulators (e.g., supplementary protection certificates, paediatric extensions).
Those dates can be different.
If you share the patent number or the jurisdiction, I can compute or state the end year precisely.